BioLineRx participated in Investor Conference in New York for Israeli Biomed companies co-sponsored by NASDAQ and TASE

December 6, 2010
PDF Version

Opening bell ceremony at NASDAQ with participants from NASDAQ-TASE Biomed Investors Conference.
VP Business Development of BioLineRx, Nir Gamliel, is  fourth on the right.
Shape
Potential life-changing treatments are on the way

Each molecule in our development pipeline is carefully selected for its potential ability to improve upon the standard of care, delivering maximum value to patients

Discover our Pipeline